Diabetes Mellitus, Type 2
Conditions
Interventions
The study will be conducted in two phases, each lasting 12 weeks. Between the two phases, there will be a time of 12 weeks between the treatments (washout), in order to eliminate the possible carryove
in addition, data on blood count, lipid profile, fasting glycemia, oxidative stress biomarker, blood pressure, anthropometry and food consumption . The sixth week of intervention of the two phases wil
Dietary supplement
SP6.051.227
Sponsors
Universidade Federal de Goiás
Universidade Federal de Goiás
Eligibility
Age
20 Years to 59 Years
Inclusion criteria
Inclusion criteria: Adult subjects; aged between 20 and 59 years; with self-reported diagnosis of type 2 diabetes mellitus
Exclusion criteria
Exclusion criteria: Individuals using insulin therapy; with a history of cardiovascular disease (infarct in the last six months, unstable angina, cardiac arrhythmia and stroke); cancer; diagnosed chronic lung disease; musculoskeletal problems ; neurological deficit; with frequent consumption of some type of nut (more than 2x / week); participants in a restriction and food education program; participants in a guided exercise program; individuals with nut and / or seeds allergy, pregnant; nursing women; women in hormonal replacement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduced levels of glycated hemoglobin, fasting insulin, fasting glycemia, Homa-IR Index and C-Reactive Protein, evaluated by the blood levels of these parameters, based on a variation of at least 5% in pre and post- intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Significant increase in HDL-cholesterol, evaluated by the blood dosage of this parameter, based on the observation of a variation of at least 5% in the pre- and post-intervention measurements;Maintenance of weight, evaluated by weighing the patient, from the observation of a variation of less than 5% in the pre- and post-intervention measurements;Maintenance of body composition, evaluated by bioimpedance, based on the observation of a variation of less than 5% in the pre- and post-intervention measurements;Maintenance of blood pressure, measured by measuring it in a semi-automatic device, based on the observation of a variation of less than 5% in the pre- and post-intervention measurements;Significant reduction of total cholesterol, LDL-cholesterol, and triglycerides, evaluated by the blood levels of these parameters, based on a variation of at least 5% in pre and post- intervention | — |
Countries
Brazil
Contacts
Public ContactBeatriz Carvalho
Universidade Federal de Goiás
Outcome results
None listed